Le Lézard
Classified in: Business
Subjects: STOCK/OTHER MARKET NEWS, TRADE ISSUES

OTC Markets Group Welcomes Thesis Gold Inc. to OTCQX


NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Thesis Gold Inc. (TSX-V: TAU; OTCQX: THSGF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Thesis Gold Inc. upgraded to OTCQX from the Pink® market.

Thesis Gold Inc. begins trading today on OTCQX under the symbol "THSGF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.

Ewan Webster, President and CEO, commented, "We are very pleased to be trading on OTCQX which will increase our visibility and accessibility to our current and prospective U.S. shareholders in addition to increasing liquidity and visibility across global capital markets."

Securities Law USA acted as the company's OTCQX sponsor.

About Thesis Gold Inc.
Thesis Gold is a mineral exploration company focused on proving and developing the resource potential of the 17,832- hectare Ranch Gold Project located in the "Golden Horseshoe" area of northern British Columbia, approximately 300 km north of Smithers, B.C.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.

Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.

OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, [email protected]



These press releases may also interest you

at 14:47
Realty ONE Group International, a modern, purpose-driven lifestyle brand and ONE of the fastest growing franchisors in the world, is focusing on its explosive growth and the success of its real estate professionals everywhere....

at 14:34
Doleco USA, the nation's fastest-growing manufacturer of lifting sling and load-securing technologies, including the DoNova PowerLash Textile Lashing Chain, PowerLift Textile Chain Sling, LayerLok Double-Decking System, Level Deck Self-Leveling...

at 14:33
Enabled Intelligence (EI), a global leader in mission-critical AI data solutions for the US Defense and Intelligence Community today announced a groundbreaking new partnership with Melwood, a leading employer, advocate, and service provider for...

at 14:31
The federal government recently delivered Budget 2024: Fairness for Every Generation. It is a plan to build a Canada that works better for everyone, where younger generations can get ahead, where their hard work pays off, and where they can buy a...

at 14:27
Kingswood U.S., part of a network of independent wealth management firms that oversees more than $14 billion in client assets globally, announced it has been named to USA Today's Best Financial Advisory Firms 2024. The award, presented by USA Today...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...



News published on and distributed by: